Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications effect pharmacotherapy attention deficit hyperactivity disorder risk seizures pediatric
Men's Health A Wealth of Experience We have collaborated with our clients on projects researching men's health, diseases related to men's health, or complications of treatment in men's health. Our experience includes: Benign prostatic hyperplasia (BPH) …
… Alicia Gilsenan Pharmacoepidemiology and Risk Management Women's Health Respiratory Oncology Men's … of expertise are pharmacoepidemiology and therapeutic risk management, as well as the structured benefit-risk assessment of medications, biologics, and devices. Since …
… longitudinal design of most trials. Moreover, there is a risk that results from cross-sectional methods may be …
… and cost-effectiveness), epidemiology (burden of illness, risk evaluation, treatment patterns, and mitigation …
… handling materials, key opinion leader interviews, and publications. Dr. Pearson’s therapy area experience includes …
… intelligence (AI) and advanced spatial analytics in a risk-adjustment framework. Called RTI Rarity™, this database … predictive analytic methods to provide localized SDOH risk scores constructed with a health equity focus. It … identify socially vulnerable populations who are at high risk of poor health outcomes, it can uncover the underlying …
… survey results of patients living with bipolar I disorder. …
Melissa Juniper Market Access and Outcomes Strategy Women's Health Respiratory Psychiatry Oncology Diabetes & Endocrine Disorders Cardiovascular Headquarters - Research Triangle Park, North Carolina, USA MS, Developmental Psychology North Carolina State …
Yi-Chun Lin Health Economics Manchester, United Kingdom MSc, Health Economics and Decision Modeler University of Sheffield, Sheffield, United Kingdom PharmD, Pharmacy National Taiwan University, Taipei, Taiwan, Province of China Yi-Chun Lin, MSc, is a …
How Much Does TLV Value Rarity? A Review of Reimbursement Maria Kinderås, MSc Senior Associate, Market Access and Outcomes Strategy Transcript Orphan drug reimbursement continues to pose significant challenges for Swedish decision-makers – due often to …